01 / Contract Profile
75A50323F80027 Federal Contract Award
Agency code 7505
EXERCISE OPTIONAL ORDERING PERIOD 2 FOR LEUKINE 250MCG VIAL INJECTABLES
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50323F80027 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$50.00M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2023 | $22.20M | 1 | — |
| FY 2024 | $41.32M | 3 | +86.1% |
| FY 2025 | $20.00M | 2 | −51.6% |
| FY 2026 | $50.00M | 2 | +150.0% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | ASPR/ORM-SNS |
05 / Contractor
Who holds this federal contract?
PARTNER THERAPEUTICS, INC.
UEI J33MSDBJZMC6 · CAGE 7ZTL0
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $133.51M | 8 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $133.51M | 8 | 100.0% |
08 / Place of Performance
Where is the work recorded?
LEXINGTON, MIDDLESEX, MASSACHUSETTS, UNITED STATES
ZIP 024215211
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jun 10, 2026 | P00007 | $34.20M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Mar 26, 2026 | P00006 | $15.80M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Sep 8, 2025 | P00005 | $0 | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| May 15, 2025 | P00004 | $20.00M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Nov 6, 2024 | P00003 | $19.11M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Oct 2, 2024 | P00002 | $0 | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Aug 5, 2024 | P00001 | $22.20M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
| Sep 26, 2023 | Base action | $22.20M | ASPR/ORM-SNSOffice code 75A503 | 325412 | 6515 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.